FDA 483 - Haleon US Inc. - September 30, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of GSK Consumer Health Inc. in Lincoln, NE, revealed significant deficiencies in quality control and manufacturing processes. The firm failed to thoroughly review out-of-specification materials and packaging defects, leading to distributed products with potential quality issues. Additionally, there were inadequate written procedures for the quality control unit, equipment cleaning, microbial control in water systems, and the drug product stability program.
ID · 62f851a1-563f-4ffc-a4ec-eb6f8d67e1b3